Full Text View
Tabular View
No Study Results Posted
Related Studies
An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease
This study has been completed.
Study NCT00106314   Information provided by Inflabloc Pharmaceuticals

First Received on March 22, 2005.   Last Updated on October 17, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Crohn's Disease
Additional conditions recognized in this trial
Crohn Disease
More general conditions related to this trial
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Inflammatory Bowel Diseases
Intestinal Diseases
Interventions listed in this trial
Dehydroepiandrosterone [DHEA]
Additional drug interventions recognized in this trial
Dehydroepiandrosterone
More general drug interventions related to this trial
Adjuvants, Immunologic
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Inflabloc Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services